Global Medicinal Foods Market is segmented By Product form (Powder, Tablet, Others), By Therapy (ADHD, Alzheimers disease, Diabetic Neuropathy, Nutritional Deficiency, Others), By Route of Administration (Oral, Enteral, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

Market Overview

The Global Medicinal Food Market is an emerging market expected to grow at a CAGR of 7.2% during the forecast period (2022-2029).

The increasing prevalence of chronic diseases and growing nutritional deficiency are the major factors driving this market.
Recommendations by doctors are further enhancing market growth, as medicinal foods play a vital role in the treatment process.
The count is expected to reach 171 million population by 2030. This continuous increase contributes to a rise in market demand.
Regarding the route of administration, oral administration takes the highest share of the market owing to its ease of administration and doctor's preferences.

Based on the product forms, the market is segmented into tablets, powders, and others.
Powders have a significant share of the market as they are consumed in the form of liquid and semi-solid. However, tablet form is expected to witness the highest growth in the market, as the dosage of the product can be appropriately managed in tablet form.
Based on therapy, the market is segmented into ADHD, Alzheimer’s disease, Diabetic Neuropathy, Nutritional Deficiency, and Others.
Based on the Route of administration, the market is segmented as Oral, Enteral, and Others.
The report segments geographies by region into North America, South America, Europe, Asia Pacific, and RoW.

The report covers factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.
It profiles the following companies: 6.1 B Braun, Abbott, Danone, Mead Johnson, Meiji Holding & Co, Fresenius, Cambrooke, Nestle Health Sciences, Perrigo, and Victus.